These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 2900525)

  • 1. The incidence of Down's syndrome and progress towards its reduction.
    Mikkelsen M
    Philos Trans R Soc Lond B Biol Sci; 1988 Jun; 319(1194):315-24. PubMed ID: 2900525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a regional screening programme using maternal serum alpha fetoprotein (AFP) and human chorionic gonadotrophin (hCG) on the birth incidence of Down's syndrome in the west of Scotland.
    Crossley JA; Aitken DA; Berry E; Connor JM
    J Med Screen; 1994 Jul; 1(3):180-3. PubMed ID: 8790513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of trisomy 21: population, peri- and antenatal data.
    Mikkelsen M
    Hum Genet Suppl; 1981; 2():211-26. PubMed ID: 6218137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Decrease in occurrence of Down's syndrome in Denmark 1980-1982. The effect of prenatal diagnosis].
    Pilgaard B; Mikkelsen M
    Ugeskr Laeger; 1985 Jan; 147(4):243-5. PubMed ID: 3156440
    [No Abstract]   [Full Text] [Related]  

  • 5. [Variations in the prevalence of Down's syndrome in the French population between 1978 and 2005].
    Rousseau T; Amar E; Ferdynus C; Thauvin-Robinet C; Gouyon JB; Sagot P
    J Gynecol Obstet Biol Reprod (Paris); 2010 Jun; 39(4):290-6. PubMed ID: 20430534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down's syndrome in South Australia.
    Sutherland GR; Clisby SR; Bloor G; Carter RF
    Med J Aust; 1979 Jul; 2(2):58-61. PubMed ID: 158701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000.
    Khoshnood B; De Vigan C; Vodovar V; Goujard J; Goffinet F
    BJOG; 2004 May; 111(5):485-90. PubMed ID: 15104615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal screening for Down's syndrome.
    Wald NJ; Kennard A; Hackshaw A; McGuire A
    J Med Screen; 1997; 4(4):181-246. PubMed ID: 9494915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of induced abortion on the incidence of Down's syndrome in Hawaii.
    Smith RG; Gardner RW; Steinhoff P; Chung CS; Palmore JA
    Fam Plann Perspect; 1980; 12(4):201-5. PubMed ID: 6449372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of demographic factors on annual Down's syndrome births in Ohio, 1970-1979, and the United States, 1920-1979.
    Huether CA; Gummere GR
    Am J Epidemiol; 1982 Jun; 115(6):846-60. PubMed ID: 6211974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability of statistics on Down's syndrome notifications.
    Huang T; Watt HC; Wald NJ; Morris JK; Mutton D; Alberman E
    J Med Screen; 1997; 4(2):95-7. PubMed ID: 9275267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
    DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
    N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief reports decline of Down's syndrome after abortion reform in New York State.
    Hansen H
    Am J Ment Defic; 1978 Sep; 83(2):185-8. PubMed ID: 151507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent trends in the prevalence and secondary prevention of Down's syndrome.
    Stone DH; Rosenberg K; Womersley J
    Paediatr Perinat Epidemiol; 1989 Jul; 3(3):278-83. PubMed ID: 2528127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal use of nutritional supplements during the first month of pregnancy and decreased risk of Down's syndrome: case-control study.
    Czeizel AE; Puhó E
    Nutrition; 2005 Jun; 21(6):698-704; discussion 774. PubMed ID: 15925294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Down's syndrome in Sweden during the years 1968-1977.
    Lindsten J; Marsk L; Berglund K; Iselius L; Ryman N; Annerén G; Kjessler B; Mitelman F; Nordenson I; Wahlström J; Vejlens L
    Hum Genet Suppl; 1981; 2():195-210. PubMed ID: 6218136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.